openPR Logo
Press release

Alpha 1-Antitrypsin Deficiency Treatment Market show exponential growth by 2024

07-13-2017 06:55 PM CET | Health & Medicine

Press release from: Transparency Market Research

Alpha 1-Antitrypsin Deficiency Treatment Market show

Alpha 1-Antitrypsin Deficiency Treatment Market: Overview

Alpha 1-antitrypsin deficiency is an inherited genetic disorder that causes insufficient production of the protein alpha 1-antitrypsin (A1AT) in individuals. A1AT is a protease inhibitor that has the capability to protect body tissues from enzymes of various inflammatory cells such as neurophil elastase. Insufficient production of this protein leads to pulmonary medical complications chronic obstructive pulmonary disease (COPD), cirrhosis and emphysema.

View Report @ http://www.transparencymarketresearch.com/alpha-1-antitrypsin-deficiency-treatment-market.html

At present, the alpha 1-antitrypsin deficiency treatment market is a highly promising and attractive market venture due to increased government support and high adoption rate for novel therapeutics. Some of the symptoms of A1AT deficiency include:

Tiredness
Vision problems
Shortness of wheezing and breath
Repeated pulmonary infections
Weight loss 
Some of the available therapeutics used for the treatment of alpha 1-antitrypsin deficiency are as follows:

Prolastin
Zemaira
Aralast
Promising drugs for treating alpha 1-antitrypsin deficiency that are still in the pipeline are as follows:

rAAV1-CB-hAAT – a recombinant adeno-associated virus vector that helps in expressing alpha-1 antitrypsin gene in individuals affected with the condition
POL-6014 – a highly potent, novel, reversible and selective inhibitor of human neutrophil elastase that might be helpful in treating alpha 1-antitrypsin deficiency
CT-2009 – a drug molecule ready for IND that can selectively disrupts RANTES and Platelet Factor 4 for treating alpha 1-antitrypsin deficiency
Alpha 1-Antitrypsin Deficiency Treatment Market: Key Growth Enablers

Geographically, Europe and North America are projected to be the leading markets for alpha 1-antitrypsin deficiency treatment due to the high prevalence and incidence rate of alpha 1-antitrypsin deficiency in these regions. It is observed that this genetic disorder is most common among North Americans of European descent and Europeans. Racial groups other than white people are expected to be affected less frequently. In the U.S., one individual per 3000 - 5000 individuals is affected by alpha 1-antitrypsin deficiency and about 25 million individuals carry one deficient gene. Both men and women are equally affected in numbers.

Get accurate market forecast and analysis on the Alpha 1-Antitrypsin Deficiency Treatment Market. Request a sample to stay abreast on the key trends impacting this market.

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=13214

Major factors propelling the growth of the alpha 1-antitrypsin deficiency treatment market are increasing incidence rate of genetic disorders and high adoption rate for novel therapeutics. Moreover, increasing government support for developing novel therapies and personalized medicines, along with high research and development initiatives on the development of stem cell based therapeutics are expected to fuel the growth of the alpha 1-antitrypsin deficiency treatment market. Furthermore, high demand for safe and effective pharmacological therapies along with increased life expectancy is expected to drive the growth of this market. In addition, technological breakthrough such as point-of-care drug delivery systems and increased focus on retaining superior quality of life are some of the factors that might contribute in the growth of this market. However, rise in overall healthcare expenditure and stringent regulatory approvals are some of the market-restraining factors that might hinder the growth of the alpha 1-antitrypsin deficiency treatment market in future.

Alpha 1-Antitrypsin Deficiency Treatment Market: Competitive Overview

At present, the treatment market for alpha 1-antitrypsin deficiency is highly consolidated due to the involvement of few players in the industry. However, it is expected that emerging biotechnological companies focused on the development of personalized medicines for genetic inherited disorders will try to achieve a significant amount of market share in the near future. Some of the companies involved in the development of therapies for treating alpha 1-antitrypsin deficiency are Baxter International Inc., CSL Behring LLC, Grifols Therapeutics, Inc., Halozyme Therapeutics, Inc., iBio, Inc., rEVO Biologics, amongst others.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Alpha 1-Antitrypsin Deficiency Treatment Market show exponential growth by 2024 here

News-ID: 623917 • Views:

More Releases from Transparency Market Research

Medical Aesthetic Devices Market Size & Share to Surpass USD 25.1 Bn by 2031, Rising at a CAGR of 7.1% - Transparency Market Research, Inc.
Medical Aesthetic Devices Market Size & Share to Surpass USD 25.1 Bn by 2031, Ri …
The medical aesthetic devices market has experienced remarkable growth in recent years, fueled by technological advancements and a growing consumer preference for minimally invasive cosmetic procedures. These devices encompass a range of technologies designed to enhance aesthetic outcomes, catering to a diverse clientele seeking innovative solutions for beauty and rejuvenation. The medical aesthetic devices market is diverse, encompassing products like aesthetic laser & energy devices, skin tightening & body contouring devices,
Liquid Biopsy Market to Reach USD 7.7 Bn by 2031, Expanding at a CAGR of 8.8%: Report by Transparency Market Research, Inc.
Liquid Biopsy Market to Reach USD 7.7 Bn by 2031, Expanding at a CAGR of 8.8%: R …
The liquid biopsy market is poised for remarkable growth, revolutionizing how we approach diagnosis and treatment in various medical fields. With its less invasive nature and potential for early disease detection, liquid biopsy is reshaping the landscape of modern medicine. This blog delves into the various aspects of the liquid biopsy market, exploring its current state, applications, key biomarkers, regional dynamics, and future trends. Liquid biopsy, a minimally invasive alternative to
Head and Neck Cancer Market Size & Share to Surpass USD 2.9 Bn, Projected to Grow CAGR 6.8% by 2031| Exclusive Report by Transparency Market Research, Inc.
Head and Neck Cancer Market Size & Share to Surpass USD 2.9 Bn, Projected to Gro …
The head and neck cancer market has witnessed significant advancements and is projected to experience robust growth in the coming years. As the global burden of cancer continues to rise, the demand for effective and innovative treatments has never been greater. The landscape of the head and neck cancer market is shaped by various drug classes and distribution channels, each playing a pivotal role in addressing the needs of patients
Gastrointestinal Pathogen Testing Market Size & Share to Surpass USD 5.2 Bn by 2031, Exhibiting a CAGR of 3.2% | Transparency Market Research, Inc.
Gastrointestinal Pathogen Testing Market Size & Share to Surpass USD 5.2 Bn by 2 …
The gastrointestinal pathogen testing market is poised for significant growth, driven by advancements in diagnostic technologies and a rising prevalence of gastrointestinal diseases. As the global population becomes more susceptible to various gastrointestinal ailments due to changing lifestyles, increased travel, and evolving dietary habits, the demand for effective and rapid pathogen testing is becoming increasingly critical. This market, which plays a vital role in the early detection and management of

All 5 Releases


More Releases for Alpha

Alpha Heater Reviews: Does Alpha Heater Really Work?
Alpha heater reviews The winter can be a tough time when it comes to one’s pocket in the sense that most people spend a lot on money on electricity bill due to the increased cost of heating and electricity. The winter is a season we all need to be prepared. It really require a careful and adequate arrangement to make sure everything is in order before its coming. As the winter
Alpha Heater in Canada: Black Friday Alpha Heater Amazon Deals
Get Alpha Heater For The Most Discounted Price >> https://rebrand.ly/AlphaHeaterCA As temperature levels remain to fall across the USA and also Canada, The Alpha Heater could be an useful home appliance, one that heats up things up effectively and also swiftly. Utilizing this device, you can bring heat into any space of your home in an efficient fashion. Plus, the dropping temperature levels, together with work-at-home norms as well as the
Alpha Heater Canada Review: Where to Buy Alpha Heater in Canada
Winter heat is a popular option with personal heaters. The Alpha Heater can be used by individuals to heat their homes or take them to work. Alpha Heater’s new design allows for 30% reductions in monthly electric bills compared to traditional heaters. Did you know that traditional heaters can consume up to 1,500 watts an hour? Others use slightly higher or lower amounts. Imagine how your electricity bill looks after a
Alpha Heater Review 2021: Shocking Facts about Alpha portable heater Reviews
Soonest, snow will be piling up on just about every doorstep around the country and you’ll be considering all options to stay warm during the winter. Don't be afraid Alpha heater Review is here to guide you through. Whether you’re a naturally cold person or want to save some money space heaters may be the answer to all your cold-weather issues. One easy way to get the job done? Alpha portable
Alpha Xtra Boost Reviews - Where to Buy Alpha Xtra Boost Pills Online?
Alpha Xtra Boost Review: As men age, their capacity to act in bed deteriorates. Numerous men find that they are unable to satisfy their accomplice in a similar fashion as they did previously. This can initiate a never-ending rify in a relationship. In their edginess, a few men consider the guidance of supplements that may induce serious side-effects. Nonetheless, these are far distant from the correct decision. Alpha Xtra Boost
Alpha Xtra Boost Reviews - Does Alpha Xtra Boost Really Work?
Reduced testosterone among men is a growing concern. However, while many consider taking the aid of chemicals for this purpose, it is instead recommended to go for dietary formulas instead. Alpha Xtra Boost is one such natural supplement that provides users with a number of ways to boost their performance in bed. Get Alpha Xtra Boost Today >> https://rebrand.ly/o0aijnb What is Alpha Xtra Boost? This is a new dietary supplement that focuses